glp-1 eye problems Focus on drugs & GLP-1 Medications and Your Vision

Learn how to spot telogen effluvium, protect protein and nutrients, and use proven treatments to stop shedding and restart healthy growth on GLP-1s

10-Meal GLP-1 Friendly Starter Pack

RCTs using dedicated retinal imaging are required to determine the causal relationship with these therapies

The proportion of patients who had ongoing treatment, regardless of previous discontinuation episodes, ranged between approximately 70% and 80% for both drugs during a 15 year period after treatment initiation across analyses using various grace periods

Federally-registered compounding facilities stopped making tirzepatide on May 22